SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

• Main Authors: Camilo C. Roa (Author), Mari Rose A. de Los Reyes (Author), Eric Plennevaux (Author), Igor Smolenov (Author), Branda Hu (Author), Faith Gao (Author), Hannalyn Ilagan (Author), Donna Ambrosino (Author), George Siber (Author), Ralf Clemens (Author), Htay Htay Han (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTWe assessed the non-inferiority of homologous boosting compared with heterologous boosting with the recombinant protein vaccine, SCB-2019, in adults previously immunized with different COVID-19 vaccines. Three equal cohorts (N ~ 420) of Philippino adults (18-80 years) previously immunized wi...